| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/05/2007 | WO2007038251A1 Alkoxy indolinone based protein kinase inhibitors |
| 04/05/2007 | WO2007038036A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | WO2007036948A1 Novel mercaptobenzimidazole substituted benzotriazole uv absorber and process for preparation thereof |
| 04/05/2007 | WO2007036533A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs |
| 04/05/2007 | WO2007036532A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 04/05/2007 | WO2007036477A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 04/05/2007 | WO2007022384A3 Pyrazine kinase inhibitors |
| 04/05/2007 | WO2007009723A3 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009702A3 Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| 04/05/2007 | WO2006124874A3 Inhibitors of b-raf kinase |
| 04/05/2007 | WO2006056695A8 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 04/05/2007 | WO2006055184A3 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 04/05/2007 | US20070079392 Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
| 04/05/2007 | US20070078266 Novel mercaptobenzimidazole substituted benzotriazole UV absorber and process for preparation thereof |
| 04/05/2007 | US20070078263 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
| 04/05/2007 | US20070078176 Keratinocyte growth factor receptor-tyrosine specific inhibitors for the prevention of cancer metastatis |
| 04/05/2007 | US20070078166 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
| 04/05/2007 | US20070078165 Melanin-concentrating hormone (MCH) receptor antagonists, such as (S)-2-{(3R,4R)-4-[6-Fluoro-2-(1-hydroxy-1-methyl-ethyl)-5-methyl-benzoimidazol-1-yl]-3 methoxy-piperidin-1-ylmethyl}-indan-5-carbonitrile, useful as dietetics, anxiolytic agents, antidepressants and anorexigenic agents |
| 04/05/2007 | US20070078150 Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 04/05/2007 | US20070078145 sodium channel modulators such as 4-{4-[3-(2,4-Dichloro-phenoxy)-propyl]-1H-imidazol-2-yl}-N-thiazol-2-yl-benzenesulfonamide; central or peripheral nervous system disorders, pain; neuropathy, inflammation |
| 04/05/2007 | US20070078140 MET kinase inhibitors |
| 04/05/2007 | US20070078138 Analogs of dehydrophenylahistins and their therapeutic use |
| 04/05/2007 | US20070078135 Substituted heteroaryl CB1 antagonists |
| 04/05/2007 | US20070078134 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot |
| 04/05/2007 | US20070078133 Useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands; for example, 5-{4-[3-({2R}-2-methyl-pyrrolidin-1-yl)-cis-cyclobutyl]-phenyl}-pyrimidine |
| 04/05/2007 | US20070078130 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases |
| 04/05/2007 | US20070078127 Control of arthropods in animals |
| 04/05/2007 | US20070078121 Enzyme modulators and treatments |
| 04/05/2007 | DE20122672U1 Modifizierte Carbocyaninfarbstoffe und deren Konjugate Modified carbocyanine and their conjugates |
| 04/05/2007 | CA2623745A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | CA2623156A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 04/05/2007 | CA2621967A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 04/05/2007 | CA2621809A1 Alkoxy indolinone based protein kinase inhibitors |
| 04/04/2007 | EP1770129A2 Modified carbocyanine dyes and their conjugates |
| 04/04/2007 | EP1770087A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments |
| 04/04/2007 | EP1770086A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments |
| 04/04/2007 | EP1768978A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/04/2007 | EP1768974A1 Substituted diketopiperazines as oxytocin antagonists |
| 04/04/2007 | EP1768972A1 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi |
| 04/04/2007 | EP1768957A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 04/04/2007 | EP1377556B1 Pyrazole derivatives for treating hiv |
| 04/04/2007 | EP1219609B1 Aromatic nitrogenous six-membered ring compounds |
| 04/04/2007 | CN1942551A New organic luminescent element |
| 04/04/2007 | CN1942465A Akt活性抑制剂 Akt activity inhibitor |
| 04/04/2007 | CN1942463A 2-aminopyridine derivative |
| 04/04/2007 | CN1942449A Process for preparing pyridazinone compounds |
| 04/04/2007 | CN1942447A Ion channel modulators |
| 04/04/2007 | CN1942188A Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides |
| 04/04/2007 | CN1939903A Mandelic acid derivatives and their use as throbin inhibitors |
| 04/04/2007 | CN1939902A Mandelic acid derivatives and their use as throbin inhibitors |
| 04/04/2007 | CN1939307A 2,4,6-triamino-1,3,5-triazine derivative |
| 04/04/2007 | CN1308326C Process for preparing indolinone derivatives |
| 04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
| 04/04/2007 | CN1307992C Eye drops containing tetrazole derivative |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199126 P38 MAP kinase; enzyme inhibitors; antiinflammatory agents; cardiovascular disorders |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199123 Pyrazine compounds as transforming growth factor (TGF) compounds |
| 04/03/2007 | US7199117 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, and learning and memory disorders; 2-[4-[4-Pyrrolidinobut-1-ynyl]phenyl]-7-methylimidazo[1,2-a]pyridine for example |
| 04/03/2007 | CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/03/2007 | CA2288140C Farnesyltransferase inhibiting quinazolinones |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 03/29/2007 | WO2007035841A1 Analogs of dehydrophenylahistins and their therapeutic use |
| 03/29/2007 | WO2007035309A1 Tyrosine kinase inhibitors |
| 03/29/2007 | WO2007034784A1 Ctgf gene expression inhibitor |
| 03/29/2007 | WO2007034326A2 Imidazole compounds for the treatment of neurological disorders |
| 03/29/2007 | WO2007034272A1 Solid salt forms of a pyrrole substituted 2-indolinone |
| 03/29/2007 | WO2007034144A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 03/29/2007 | WO2007034143A1 Quinazoline derivatives as anticancer agents |
| 03/29/2007 | WO2007016589A3 Inhibitors of serine proteases |
| 03/29/2007 | WO2007013096A8 Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) |
| 03/29/2007 | WO2007012849A3 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
| 03/29/2007 | WO2007009721A3 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 03/29/2007 | WO2007008985A3 Kinase inhibitors |
| 03/29/2007 | WO2006132914A3 Cyclobutyl amine derivatives |
| 03/29/2007 | WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists |
| 03/29/2007 | WO2006060424A3 Inducible nitric oxide synthase dimerization inhibitors |
| 03/29/2007 | WO2006029209A3 Method for activating trpv4 channel receptors by agonists |
| 03/29/2007 | WO2005109987A9 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 03/29/2007 | WO2005092066A8 Imidazole compounds |
| 03/29/2007 | US20070073064 Method for producing aminopyrrolidine derivatives and intermediate compounds |
| 03/29/2007 | US20070073063 Preparing high purity, e.g., 4,4'-oxybis(N-methylphthalimide by contacting a solution of an oxybisphthalimide, a solvent, and an organic phase transfer catalyst with a solid inorganic adsorbent having a cumulative pore volume distribution of at least 20 %; free of residual phase transfer catalyst. |
| 03/29/2007 | US20070073062 Such as 1-Benzyl-1a,3,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid; for treatment of dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X |
| 03/29/2007 | US20070073056 4-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 03/29/2007 | US20070072934 inhibitors of protein kinases and are useful in treating cancer; 4-({5-[5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carbonyl}-amino)-3-methoxy-butyric acid; anticarcinogenic agent |
| 03/29/2007 | US20070072929 2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethyl 4-[(aminocarbonothioyl)amino]-4-oxobutanoate;potententiation; anaerobic/ aerobic microoraganisms; grampositive,gramnegative bacteria; Campylobacter; respiratory system disorders; paraciticides; nontoxic; enzymers/hydrolases/;enzyme inhibitors |
| 03/29/2007 | US20070072924 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 03/29/2007 | US20070072922 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 03/29/2007 | US20070072919 Preparing perindopril by reacting 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanine and octahydro 1H-indole-2-carboxylic acid or its ester with a uronium salt (O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate) in the presence of a tertiary amine in an aprotic solvent |
| 03/29/2007 | US20070072913 Thermodynamically stable at room temperature, nonhygroscopic |
| 03/29/2007 | US20070072912 Alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants |
| 03/29/2007 | US20070072911 Indoles and azaindoles as antiviral agents |
| 03/29/2007 | US20070072909 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 03/29/2007 | US20070072908 Heterocyclic compounds |
| 03/29/2007 | US20070072906 Pyrrole compounds |
| 03/29/2007 | US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 03/29/2007 | US20070072897 1-[5-(benzyloxy)-1H-indol-1-yl]-3-(methylamino)-1-phenylpropan-2-ol;fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 03/29/2007 | US20070072885 Bicyclic derivatives for the treatment of abnormal cell growth |
| 03/29/2007 | US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |